Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per ordinary share. The dividend is payable on February 20, 2014, to shareholders of record on January 28, 2014.
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien develops, manufactures and sells a diverse range of industry-leading medical device and supply products. With 2013 revenue of $10.2 billion, Covidien has more than 38,000 employees worldwide in more than 70 countries, and its products are sold in over 150 countries. Please visit
www.covidien.com to learn more about our business.